NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
1.960
+0.060 (3.16%)
At close: Aug 14, 2026, 4:00 PM EDT
1.970
+0.010 (0.49%)
After-hours: Aug 14, 2026, 7:55 PM EDT
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $226.67 million as of August 14, 2026. Its market cap has decreased by -53.51% in one year.
Market Cap
226.67M
Enterprise Value
18.90M
1-Year Change
-53.51%
Ranking
Category
Stock Price
$1.96
ChartMarket Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $226.67M, an increase of 64.20%. That is a compound annual growth rate of 7.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 226.67M | -50.60% |
| Dec 31, 2025 | 458.86M | 562.90% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Galectin Therapeutics | 232.47M |
| Compugen | 228.29M |
| Alector | 227.78M |
| Immunic | 225.84M |
| AN2 Therapeutics | 225.66M |
| Arcturus Therapeutics Holdings | 223.41M |
| Cellectis | 223.20M |
| Tonix Pharmaceuticals Holding | 214.39M |